Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
ESOC 2026
Incident ischaemic stroke in the randomised, placebo-controlled, event-driven OCEANIC-STROKE trial of asundexian for secondary stroke prevention: Severity, treatment and outcomes
Date/Time:
Wednesday, May 6, 2026 | 11:51 AM – 12:01 PM, CEST
Presenting Author:
Mukul Sharma
Presentation Session
Official Welcome & Large Clinical Trials (LB157)
Net benefit and time course of benefit of asundexian for secondary stroke prevention in the OCEANIC-STROKE randomised, placebo-controlled clinical trial
Date/Time:
Friday, May 8, 2026 | 9:15 AM – 9:24 PM, CEST
Presenting Author:
Mukul Sharma
Presentation Session
Late Breaking Trials Across the Stroke Care Continuum (LB158)
Posters
Intracranial haemorrhage in patients with non-cardioembolic ischaemic stroke or high-risk TIA: Insights from the OCEANIC-STROKE randomised trial of asundexian for secondary stroke prevention
Date/Time:
Wednesday, May 6, 2026 | 1:00 PM, CEST
Presenting Author:
Ashkan Shoamanesh
Poster Session:
Paper Poster Presentation Session (LB160)
Predictors of recurrent ischaemic stroke in patients with non-cardioembolic ischaemic stroke: Insights from the OCEANIC-STROKE randomised trial of asundexian for secondary stroke prevention
Date/Time:
Wednesday, May 6, 2026 | 1:00 PM, CEST
Presenting Author:
Ashkan Shoamanesh
Poster Session:
Paper Poster Presentation Session (LB159)
Medication patterns by stroke severity in non-cardioembolic ischaemic stroke: Findings from a large, nationally representative US-based retrospective observational database
Date/Time:
Thursday, May 7, 2026 | 1:00 PM, CEST
Presenting Author:
Sean Savitz
Poster Session:
Paper Poster Presentation Session (A1430)
© 2026 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.
Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.
For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/
PP-GEN-ALL-0014-1
